HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Bruce D Gelb Selected Research

Pycnodysostosis

3/2009Ablation of cathepsin k activity in the young mouse causes hypermineralization of long bone and growth plates.
6/2006Mice lacking cathepsin K maintain bone remodeling but develop bone fragility despite high bone mass.
4/2004Decreased bone turnover and deterioration of bone structure in two cases of pycnodysostosis.
8/2002Collagenase activity of cathepsin K depends on complex formation with chondroitin sulfate.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Bruce D Gelb Research Topics

Disease

24Noonan Syndrome (Female Pseudo-Turner Syndrome)
01/2020 - 10/2002
8Congenital Heart Defects (Congenital Heart Defect)
01/2021 - 03/2004
7LEOPARD Syndrome (Syndrome, LEOPARD)
04/2015 - 02/2006
6Neoplasms (Cancer)
01/2020 - 04/2009
4Marfan Syndrome (Marfan's Syndrome)
01/2020 - 05/2013
4Hypertrophic Cardiomyopathy (Hypertrophic Obstructive Cardiomyopathy)
04/2018 - 03/2011
4Pycnodysostosis
03/2009 - 08/2002
3Inborn Genetic Diseases (Disease, Hereditary)
01/2022 - 01/2014
3Heart Failure
04/2018 - 06/2014
3Cardiomegaly (Heart Hypertrophy)
04/2015 - 03/2011
3Deafness (Deaf Mutism)
06/2010 - 11/2002
2Plexiform Neurofibroma
11/2022 - 01/2020
2Sarcoma (Soft Tissue Sarcoma)
04/2021 - 09/2012
2Inflammation (Inflammations)
11/2020 - 07/2020
2Carcinogenesis
01/2020 - 10/2015
2Rare Diseases (Rare Disease)
04/2016 - 04/2014
2Hypertrophy
01/2016 - 07/2011
2Patent Ductus Arteriosus
04/2015 - 11/2003
2Osteosclerosis
03/2009 - 04/2004
2Diabetes Mellitus
02/2004 - 11/2002
2Megaloblastic Anemia
02/2004 - 11/2002
1Neurofibromatosis 1 (Neurofibromatosis Type I)
11/2022
1Heart Diseases (Heart Disease)
01/2022
1Headache (Headaches)
12/2020
1Spondylosis
12/2020
1Migraine Disorders (Migraine)
12/2020
1Post-Traumatic Headache
12/2020
1Infections
07/2020
1Left Ventricular Outflow Obstruction
04/2020
1Nerve Sheath Neoplasms (Nerve Sheath Neoplasm)
01/2020
1Necrosis
01/2020
1Neurodevelopmental Disorders
01/2018
1Myocarditis (Carditis)
04/2017
1Atrioventricular Septal Defect
04/2016
1Lymphoma (Lymphomas)
08/2015
1Cardiomyopathies (Cardiomyopathy)
07/2015
1Bicuspid Aortic Valve Disease
04/2015
1Ventricular Heart Septal Defects (Ventricular Septal Defect)
04/2015
1Aortic Coarctation
04/2015
1Double Outlet Right Ventricle
04/2015
1Aortic Aneurysm (Aneurysm, Aortic)
01/2014
1Acrocephalosyndactylia (Apert Syndrome)
06/2013
1Multiple Endocrine Neoplasia Type 2b (MEN 3)
06/2013
1Aortic Dissection
05/2013
1Abdominal Aortic Aneurysm
01/2012

Drug/Important Bio-Agent (IBA)

13Proteins (Proteins, Gene)FDA Link
01/2022 - 02/2006
11Mitogen-Activated Protein KinasesIBA
01/2022 - 10/2006
7Protein Tyrosine PhosphatasesIBA
08/2012 - 10/2002
5Cathepsin KIBA
01/2012 - 08/2002
4Mitogen-Activated Protein Kinase Kinases (MEKs)IBA
11/2022 - 09/2012
3Monomeric GTP-Binding ProteinsIBA
04/2020 - 01/2018
3Phosphotransferases (Kinase)IBA
01/2020 - 04/2009
3Atenolol (Tenormin)FDA LinkGeneric
01/2020 - 05/2013
3Losartan (Cozaar)FDA LinkGeneric
01/2020 - 05/2013
3CollagenIBA
04/2016 - 08/2002
2AZD 6244IBA
11/2022 - 01/2020
2Transcription Factors (Transcription Factor)IBA
01/2022 - 05/2010
2CytokinesIBA
11/2020 - 07/2020
2Non-Receptor Type 11 Protein Tyrosine PhosphataseIBA
01/2020 - 03/2011
2ChromatinIBA
10/2019 - 01/2018
2DNA (Deoxyribonucleic Acid)IBA
04/2015 - 03/2004
2Sirolimus (Rapamycin)FDA Link
04/2015 - 06/2014
2Phosphoric Monoester Hydrolases (Phosphatases)IBA
01/2009 - 03/2004
2Insulin (Novolin)FDA Link
12/2008 - 11/2002
2EnzymesIBA
06/2006 - 04/2004
2Thiamine (Aneurin)FDA Link
02/2004 - 11/2002
1Bone Morphogenetic Protein 2IBA
01/2021
1AutoantibodiesIBA
07/2020
1AntigensIBA
07/2020
1Protein Kinases (Protein Kinase)IBA
01/2020
1Triglycerides (Triacylglycerol)IBA
01/2020
1Mitogen-Activated Protein Kinase 1 (p42 MAP Kinase)IBA
01/2020
1Cytochrome P-450 CYP2C9IBA
01/2020
1TOR Serine-Threonine KinasesIBA
04/2018
1diazonaphthalenedisulfonic acid (NDS)IBA
01/2018
1InterferonsIBA
04/2017
1SH2 Domain-Containing Protein Tyrosine PhosphatasesIBA
01/2017
1Ryanodine Receptor Calcium Release Channel (Ryanodine Receptor)IBA
04/2016
1RNA (Ribonucleic Acid)IBA
01/2016
1CalciumIBA
01/2016
1Transforming Growth Factors (Transforming Growth Factor)IBA
01/2016
1Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA
11/2015
1MicroRNAs (MicroRNA)IBA
10/2015
1Ligases (Synthetase)IBA
08/2015
112- (4'- azido- 2'- nitrophenoxy)dodecanoyl- coenzyme AIBA
04/2015
15' Untranslated Regions (5' UTR)IBA
04/2015
1Brain Natriuretic Peptide (Natrecor)FDA Link
04/2015
1GTP Phosphohydrolases (GTPases)IBA
08/2014
1Pharmaceutical PreparationsIBA
04/2014
1Histones (Histone)IBA
06/2013
1tyrosine receptor (receptor, tyrosine)IBA
06/2013
1Cyclin D1IBA
06/2013
1Codon (Codons)IBA
08/2012
1Pancreatic Elastase (Elastase)IBA
01/2012
1Cyclosporine (Ciclosporin)FDA LinkGeneric
07/2011

Therapy/Procedure

9Therapeutics
11/2022 - 11/2003
1Injections
12/2020
1Art Therapy
01/2020
1Mechanical Ventilators (Ventilator)
01/2020
1Palliative Care (Palliative Therapy)
04/2015